Relmada Therapeutics Inc (RLMD) — Working Capital to Net Assets Ratio
Relmada Therapeutics Inc (RLMD) has a Working Capital to Net Assets ratio of 101.7% as of March 2026. Working capital of $222.45 Million (current assets of $235.34 Million minus current liabilities of $12.89 Million) is measured against net assets of $218.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See RLMD financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Relmada Therapeutics Inc Working Capital to Net Assets (2012–2025)
This chart shows how Relmada Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 101.7%, reflecting working capital of $222.45 Million against net assets of $218.73 Million USD. See operational self-sufficiency of Relmada Therapeutics Inc to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Relmada Therapeutics Inc (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Relmada Therapeutics Inc from 2012 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Relmada Therapeutics Inc worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 101.2% | $87.55 Million | $86.51 Million | $93.98 Million | $6.43 Million | ▲ +1.3 pp |
| 2024 | 100.0% | $35.50 Million | $35.52 Million | $45.80 Million | $10.29 Million | ▲ +0.0 pp |
| 2023 | 99.9% | $85.31 Million | $85.36 Million | $97.51 Million | $12.19 Million | ▼ 0.0 pp |
| 2022 | 100.0% | $140.40 Million | $140.44 Million | $152.87 Million | $12.47 Million | ▼ 0.0 pp |
| 2021 | 100.0% | $208.24 Million | $208.26 Million | $223.30 Million | $15.06 Million | ▲ +0.1 pp |
| 2020 | 99.9% | $105.47 Million | $105.58 Million | $118.07 Million | $12.60 Million | ▲ +0.1 pp |
| 2019 | 99.8% | $115.48 Million | $115.68 Million | $116.94 Million | $1.46 Million | ▲ +42.4 pp |
| 2018 | 57.4% | $-3.17 Million | $-5.51 Million | $2.74 Million | $5.90 Million | ▼ -17.8 pp |
| 2017 | 75.2% | $1.10 Million | $1.46 Million | $2.47 Million | $1.38 Million | ▼ -13.4 pp |
| 2016 | 88.6% | $6.24 Million | $7.04 Million | $9.30 Million | $3.06 Million | ▼ -6.6 pp |
| 2015 | 95.2% | $8.39 Million | $8.81 Million | $23.97 Million | $15.58 Million | ▲ +0.0 pp |
| 2014 | 95.2% | $8.39 Million | $8.81 Million | $23.97 Million | $15.58 Million | ▲ +2.2 pp |
| 2014 | 93.0% | $-1.03 Million | $-1.11 Million | $25.74 Million | $26.77 Million | ▲ +0.0 pp |
| 2013 | 93.0% | $-1.03 Million | $-1.11 Million | $25.74 Million | $26.77 Million | ▼ -7.0 pp |
| 2012 | 100.0% | $11.36K | $11.36K | $18.35K | $7.00K | — |